ZICHE, MARINA
 Distribuzione geografica
Continente #
NA - Nord America 18.031
EU - Europa 12.816
AS - Asia 7.715
SA - Sud America 1.255
AF - Africa 260
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 6
Totale 40.105
Nazione #
US - Stati Uniti d'America 17.842
GB - Regno Unito 3.537
CN - Cina 2.749
SG - Singapore 2.308
RU - Federazione Russa 2.179
IE - Irlanda 1.776
UA - Ucraina 1.242
BR - Brasile 1.066
SE - Svezia 1.038
VN - Vietnam 855
FR - Francia 814
IT - Italia 750
DE - Germania 718
HK - Hong Kong 598
KR - Corea 419
FI - Finlandia 403
IN - India 248
BD - Bangladesh 98
TR - Turchia 97
CA - Canada 94
ZA - Sudafrica 78
AR - Argentina 76
ES - Italia 68
IQ - Iraq 58
MX - Messico 55
NG - Nigeria 55
NL - Olanda 51
PL - Polonia 45
BE - Belgio 44
ID - Indonesia 35
JP - Giappone 34
CI - Costa d'Avorio 32
PK - Pakistan 30
EC - Ecuador 29
AT - Austria 25
MA - Marocco 25
SA - Arabia Saudita 23
KE - Kenya 20
NP - Nepal 19
UZ - Uzbekistan 19
VE - Venezuela 19
AU - Australia 18
CO - Colombia 18
CL - Cile 17
DZ - Algeria 17
LT - Lituania 15
PH - Filippine 14
IL - Israele 13
JO - Giordania 13
BG - Bulgaria 12
CZ - Repubblica Ceca 12
PY - Paraguay 11
RO - Romania 11
AE - Emirati Arabi Uniti 10
EG - Egitto 9
AZ - Azerbaigian 8
BY - Bielorussia 8
CR - Costa Rica 8
PE - Perù 8
PT - Portogallo 8
GR - Grecia 7
KG - Kirghizistan 7
MY - Malesia 7
AM - Armenia 6
DK - Danimarca 6
EE - Estonia 6
EU - Europa 6
HU - Ungheria 6
OM - Oman 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
AL - Albania 5
IR - Iran 5
JM - Giamaica 5
SN - Senegal 5
TN - Tunisia 5
BA - Bosnia-Erzegovina 4
BH - Bahrain 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
GT - Guatemala 4
KH - Cambogia 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
PA - Panama 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
AO - Angola 3
CH - Svizzera 3
CY - Cipro 3
HN - Honduras 3
HR - Croazia 3
LB - Libano 3
MM - Myanmar 3
MN - Mongolia 3
SY - Repubblica araba siriana 3
DM - Dominica 2
GE - Georgia 2
Totale 40.078
Città #
Southend 3.222
Fairfield 1.982
Dallas 1.897
Dublin 1.759
Singapore 1.378
Ashburn 1.376
Chandler 1.068
Jacksonville 1.009
Woodbridge 939
Houston 891
Seattle 800
Wilmington 782
Cambridge 679
San Jose 640
Moscow 585
Hong Kong 570
Santa Clara 543
Beijing 539
Ann Arbor 464
Hefei 454
Seoul 417
Princeton 363
The Dalles 337
Nanjing 312
Ho Chi Minh City 236
Los Angeles 224
Siena 205
Hanoi 189
Lauterbourg 186
Boardman 160
San Diego 152
Helsinki 150
Menlo Park 148
Council Bluffs 137
Nanchang 126
New York 120
San Mateo 115
Dong Ket 108
Columbus 106
Buffalo 103
Fremont 101
Pune 85
Tianjin 85
São Paulo 79
Shenyang 74
Munich 73
Kunming 67
Izmir 63
Johannesburg 57
Bengaluru 55
Hebei 52
London 52
Redondo Beach 52
Abuja 51
Orem 50
Florence 47
Da Nang 46
Changsha 45
Brussels 44
Turku 43
Milan 41
Jinan 40
Shanghai 40
Warsaw 40
San Francisco 39
Zhengzhou 38
Dearborn 37
Toronto 37
Málaga 36
Norwalk 35
Atlanta 34
Abidjan 32
Chicago 32
Rome 32
Chennai 31
Frankfurt am Main 31
Düsseldorf 30
Haiphong 30
Jiaxing 30
Falls Church 29
Hangzhou 29
Lancaster 29
Tokyo 28
Amsterdam 27
Brooklyn 27
Nuremberg 27
Redwood City 27
Guangzhou 26
Belo Horizonte 23
Rio de Janeiro 23
Stockholm 23
Phoenix 22
Poplar 22
Mexico City 21
Jakarta 19
Ningbo 19
Denver 18
Manchester 18
Nairobi 18
Taizhou 18
Totale 27.850
Nome #
Inhibition of hypoxia inducible factor-1alpha by dihydroxyphenylethanol, a product from olive oil, blocks microsomal prostaglandin-E synthase-1/vascular endothelial growth factor expression and reduces tumor angiogenesis 438
Formulation of liposomes functionalized with the Lotus lectin and effective in targeting highly proliferative cells 417
A fucose-containing O-glycoepitope on bovine and human nucleolin 384
ALDH3A1 overexpression in melanoma and lung tumors drives cancer stem cell expansion, impairing immune surveillance through enhanced PD-L1 output 348
ALDH2 activity reduces mitochondrial oxygen reserve capacity in endothelial cells and induces senescence properties 328
Involvement of bradykinin B2 receptor in pathological vascularization in oxygen-induced retinopathy in mice and rabbit cornea 309
Monitoring endothelial and tissue responses to cobalt ferrite Nanoparticles and Hybrid Hydrogels 301
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 296
Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells 295
EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity 294
B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects 294
Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation 291
Targeting endothelial-to-mesenchymal transition: the protective role of hydroxytyrosol sulfate metabolite 291
A nanoscale fluorocarbon coating on PET surfaces improves the adhesion and growth of cultured coronary endothelial cells 273
PGE2 mediates EGFR internalization and nuclear translocation via caveolin endocytosis promoting its transcriptional activity and proliferation in human NSCLC cells 268
Antagonism of bradykinin B2 receptor prevents inflammatory responses in human endothelial cells by quenching the NF-kB pathway activation. 265
4-Substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof 265
Angiogenic polypeptides in breast cancer: expression of MRNA’s in primary human tumours, MCF-7 cell transfection and xenograft models 259
PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells 256
Divergent effects of quercetin conjugates on angiogenesis 254
mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines 254
The effect of hydroxyapatite nanocrystals on microvascular endothelial cell viability and functions 251
Characterization of zofenoprilat as an inducer of functional angiogenesis through increased H2 S availability 251
Bradykinin B2 receptor contributes to inflammatory responses in human endothelial cells by the transactivation of the fibroblast growth factor receptor FGFR-1 250
Antiangiogenic properties of selected ruthenium(III) complexes that are nitric oxide scavengers 249
H2S dependent and independent anti-inflammatory activity of zofenoprilat in cells of the vascular wall 249
Abolished angiogenicity and tumorigenicity of Burkitt's lymphoma by Interleukin-10 246
Endothelial Aldehyde Dehydrogenase 2 as a Target to Maintain Vascular Wellness and Function in Ageing 246
Real word evidence on rituximab utilization: Combining administrative and hospital-pharmacy data 245
Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin 242
Analysis of the role of chemokines in angiogenesis 241
Biological characterization of nanocomposite hydrogels 241
RNA-mediated gene silencing of FUT1 and FUT2 influences expression and activities of bovine and human fucosylated nucleolin and inhibits cell adhesion and proliferation 240
Peroxynitrite inactivates human-tissue inhibitor of metalloproteinase-4 240
Miniaturizing VEGF: Peptides mimicking the discontinuous VEGF receptor-binding site modulate the angiogenic response 236
Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer 236
Evidence of β-blockers drug repurposing for the treatment of triple negative breast cancer: A systematic review 236
Targeting PGE2 Signaling in Tumor Progression and Angiogenesis 232
Studying vascular angiogenesis and senescence in zebrafish embryos 232
Activity of "NO-donor" or "NO-mediated" drugs 231
Synergism between gangliosides and basic fibroblastic growth factor in favouring survival, growth, and motility of capillary endothelium. 230
c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro 229
A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases 223
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathways 222
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line 219
VEGF induces signalling and angiogenesis by directing VEGFR2 internalisation through macropinocytosis 219
Absence of PAF actions increases angiogenesis 215
A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through a5b1 integrin 215
How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance 214
Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial Cells 212
ALDH1A1 overexpression in melanoma cells promotes tumor angiogenesis by activating the IL‑8/Notch signaling cascade 212
Aminoflavone, a ligand of the Aryl Hydrocarbon Receptor (AhR), inhibits HIF-1α expression in an AhR-independent fashion 211
A novel protein from the serum of Python sebae, structurally homologous with type-γ phospholipase A2 inhibitor, displays antitumour activity 211
Stemness marker ALDH1A1 promotes tumor angiogenesis via retinoic acid/HIF-1α/VEGF signalling in MCF-7 breast cancer cells 211
Functional and pharmacological characterization of a VEGF mimetic peptide on reparative angiogenesis 208
Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells 208
Assessing vascular senescence in zebrafish 207
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signaling 207
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 207
An angiogenic role for the neurotrophins midkine and pleiotrophin in tumorigenesis. 206
Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants 205
MPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity 205
Abeta peptides accelerate the senescence of endothelial cells in vitro and in vivo, impairing angiogenesis 204
Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. 203
Role of nitric oxide in the modulation of angiogenesis 202
Differential contribution of bradykinin receptors in angiogenesis 201
The effect of linomide on the migration and the proliferation of capillary endothelial cells elicited by vascular endothelial growth factor 199
Pharmacological inhibition of microsomal prostaglandin e synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis. 199
Derivati 4-sostituiti della 1-(2-cloro-2-feniletil)-1H-pirazolo[3,4-d]pirimidina e loro usi. 198
Activation of MAPK in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats 198
The rabbit corneal pocket assay 197
Angiogenesis 196
Nitric oxide in tumor angiogenesis 193
Role of prostaglandin E1 and copper in angiogenesis 192
PKCε ACTIVATION PROMOTES FGF-2 EXOCYTOSIS AND INDUCES ENDOTHELIAL CELL PROLIFERATION AND SPROUTING 191
The sulphydryl containing ACE inhibitor Zofenoprilat protects coronary endothelium from Doxorubicin-induced apoptosis 191
Nitric oxide releasing metal-diazeniumdiolate complexes strongly induce vasorelaxation and endothelial cell proliferation 190
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 190
Cu(II) and Zn(II) complexes with hyaluronic acid and its sulphated derivativederivative. Effect on the motility of vascular endothelial cells 189
Nitric oxide synthase lies downstream of vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis 189
Molecular mechanisms of resistance to anti-angiogenic drugs 188
New tools for the study of cGMP dependent functions: validation in VEGF induced permeability and angiogenesis 187
Targeting endothelial cell metabolism for cardio-protection from the toxicity of antitumor agents 187
Angiotensin II potentiates the mitogenic effect of noradrenaline in vascular smooth muscle cells via AT1 receptors 185
Physiological levels of amyloid peptides stimulate the angiogenic response through FGF-2 184
Nitric oxide and angiogenesis 182
The effect of thiorphan on release of sensory neuropeptides from guinea-pig cerebral venous sinuses 182
Chapter 2. Antiangiogenic drugs: Chemosensitizers for combination cancer therapy 182
In vitro and in vivo models to study chemokine regulation of angiogenesis 181
The corneal pocket assay 181
Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P 180
Inflammation and tumor progression: role of prostaglandin E2 pathway 176
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. 175
In vitro and in vivo activation of endothelial cells by colony-stimulating factors 175
PKCepsilon activation promotes FGF-2 exocytosis and induces endothelial cell proliferation and sprouting 175
Sulfhydryl angiotensin-converting enzyme inhibitor promotes endothelial cell survival through nitric-oxide synthase, fibroblast growth factor-2, and telomerase cross-talk 175
deltaPKC inhibition or epsilonPKC activation repairs endothelial vascular dysfunction by regulating eNOS post-translational modification 174
Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit 174
Repurposing of drugs for triple negative breast cancer: an overview 174
The natural compound n-butylidenephthalide derived from the volatile oil of Radix Angelica sinensis inhibits angiogenesis in vitro and in vivo 173
Totale 22.782
Categoria #
all - tutte 125.447
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.447


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021333 0 0 0 0 0 0 0 0 0 0 0 333
2021/20222.838 187 392 153 349 122 120 133 122 105 327 245 583
2022/20233.805 248 272 497 589 387 778 51 288 406 69 125 95
2023/20242.371 115 50 155 187 62 696 835 56 3 26 16 170
2024/20254.812 88 292 407 301 452 193 95 298 347 216 606 1.517
2025/202611.542 1.022 1.804 1.417 1.218 2.255 478 1.632 299 460 582 245 130
Totale 40.334